Cello Group plc  

(Public, LON:CLL)   Watch this stock  
Find more results for Paul L. Chello
97.50
+0.50 (0.52%)
Jul 25 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
Range 96.00 - 98.00
52 week 77.10 - 104.00
Open 97.00
Vol / Avg. 89,148.00/81,762.00
Mkt cap 85.30M*
P/E 28.38
Div/yield 2.02*
EPS 0.03*
Shares 86.75M
Beta     -
Inst. own     -
*GBP
May 11, 2016
Cello Group plc Annual Shareholders Meeting (Estimated)
  

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin 2.53% 1.94%
Operating margin 4.07% 3.27%
EBITD margin - 6.98%
Return on average assets 3.33% 2.44%
Return on average equity 5.79% 4.34%
Employees 940 -
CDP Score - -

Address

11-13 Charterhouse Buildings
LONDON, EC1M 7AP
United Kingdom - Map
+44-20-78128460 (Phone)
+44-20-72535376 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance

Description

Cello Group plc is a United Kingdom-based healthcare and consumer strategic marketing company. The Company is engaged in providing market research, consulting and direct marketing services. The Company operates through two segments: Cello Health and Cello Signal. The Cello Health Division provides market research, consulting and communications services principally to the Company's pharmaceutical and healthcare clients. The Cello Signal Division provides market research and direct communications services principally to the Company's consumer facing clients. The Company delivers its services from office networks in the United Kingdom, the United States, Singapore and Hong Kong. The Company's subsidiaries include 2CV Limited, Cello Group Inc, Farm Communications Limited, Market Research International Limited and Insight Medical Research Limited.

Officers and directors

Mark Scott Chief Executive, Executive Director
Mark Bentley Group Finance Director, Company Secretary, Executive Director
Stephen Highley Group Corporate Development Director, Director
Allan Rich Independent Non-Executive Chairman of the Board
William Nigel David Independent Non-Executive Director
Paul Hamilton Senior Independent Non Executive Director